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ABSTRACT  
Diabetes mellitus is one of the most common endocrine disorder which causes microvascular and macrovascular complications. Several 
synthetic drugs used to treat diabetes have adverse effects on prolonged usage. This has given the impetus to the search for alternative 
medicines with no or less side effects. The plants of Orchidaceae family have displayed antimicrobial, anti-inflammatory, antioxidant, anticancer 
and antidiabetic activity. However, their antidiabetic properties are yet to be explored. This study sought to evaluate the antidiabetic potentials 
of hydroalcoholic extract of root of Dactylorhiza hatagirea (D. hatagirea) in diabetic rats. Qualitative analysis of various phytochemical 
constituents and quantitative analysis of total flavonoids were determined by the well-known test protocol available in the literature and 
quercetin was detected in hydroalcoholic extract of root of D. hatagirea under study by using RP-HPLC analysis. Percentage inhibition of α-
amylase activity by D. hatagirea root extract was estimated with acarbose as the positive control, D. hatagirea extract show dose dependent 
activity. IC50 value of acarbose and extract was found to 35.33 and 224.45 µg/ml respectively. Diabetes was induced in wistar albino rats by 
administration of alloxan monohydrate (120 mg/kg; i.p.). The of hydroalcoholic extract of D. hatagirea at a dose of 100 and 200 mg/kg body 
weight was administrated at a single dose per day to diabetes-induced rats for a period of 15 day. The effect of hydroalcoholic extract of D. 
hatagirea root on blood glucose, total cholesterol (TR), triglycerides (TG), total protein and body weight were measured in the diabetic rats. The 
effect of hydroalcoholic extract of D. hatagirea root elicited significant reduction in blood glucose (p<0.001), (p<0.01), lipid parameters (TC, TG, 
total protein) (p<0.01) and significantly increased body weight at the dose of 200 mg/kg when compared with the diabetic-induced control. For 
future studies, phytochemcials responsible for various activities can be isolated and modified for pharmacological purpose.This study, 
therefore, justifies the use of the plant in the treatment of diabetes mellitus. 
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INTRODUCTION 
Diabetes is characterized by hyperglycemia, altered lipids, 
carbohydrates and proteins metabolism which affect the 
patient quality of life in terms of social, psychological well-
being as well as physical ill health1,2. Two forms of diabetes 
(Types 1 and 2) differ in their pathogenesis, but both have 
hyperglycemia as a common hall mark. In type 2 diabetes, 
hyperglycemia caused due to impairment in insulin 
secretion combined with or without impairment of insulin 
action3. The World Health Organization reported that 
worldwide global population is in the midst of a diabetes 
epidemic. The people in Southeast Asia and Western Pacific 
are being under greater risk and the majority of patients 
have type 2 diabetes. Insulin resistance typically precedes 
the onset of type 2 diabetes and is commonly accompanied 
by other cardiovascular risk factors such as dyslipidemia, 
hypertension and prothrombotic factors4.Diabetes-related 
cardiovascular complications occur due to altered 
lipoprotein metabolism-mediated atherosclerosis and 
diabetics are 2 to 4 times more likely to suffer from stroke5. 
Although different classes of drugs are available to control 
type 2 diabetes, still it is a challenging task to bring a better 
molecule which is devoid of undesirable adverse effects than 
existing drugs. In Indian traditional medicine systems, the 
number of medicinal plants has been used since ancient time 
to effectively treat diabetes6. Multiple mechanisms, due to 
many phytoconstituents were documented for the 
antidiabetic activity of medicinal plants. Therefore, 
documenting the efficacy of antidiabetic medicinal plants 
has been increased and their characterizations of chemical 
constituents are focused in drug discovery programmes to 
bring a better lead molecule to treat diabetes7. The genus 
Dactylorhiza (Orchidaceae) is represented by approximately 
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75 species, distributed in most parts of Northern temperate 
zone. D. hatagirea (D. Don) Soo is a perennial orchid, native 
to the Himalayan region8. This species is distributed in India, 
Pakistan, Afghanistan, Nepal, Tibet and Bhutan. In India, it is 
distributed in Jammu and Kashmir9, Uttarakhand10-12 and 
Himachal Pradesh13. D. hatagirea is also a high-value 
medicinal orchid used in Ayurveda, Siddha and Unani 
medicine14. It is widely used to cure various diseases 
including dysentery, diarrhea, chronic fever, cough, 
stomachache, wounds, cuts, burns, fractures, and general 
weakness. The rhizomes of D. hatagirea contain bitter 
substance, glucoside mucilage, albumen, starch, a trace of 
volatile oil and ash15. Chemically, dactylorhins A to E, 
dactyloses A and B, lipids, and so on are found as major 
constituents. The tubers of this species yield a high quality 
salep which is used as a tonic to increase immunity 
(immunomodulator) and as a vajikaran drug (aphrodisiac); 
it increases sexual performance as well as serving as a 
nervine tonic16. Recently herbal health beverages have also 
been developed from this species17. Tubers of this species 
are supposed as a potent medicine in Leucorrhea in 
Traditional System of Medicine (TSM). Hence, there is a need 
for a more effective drug with lower side effects. Therefore, 
the present study was aimed to investigate in vitro and 
vivo antidiabetic activity of hydroalcoholic extracts of D. 
hatagirea in type 2 diabetic rats. The phytoconstituents 
(biomarkers) present in extract were characterized by high-
performance liquid chromatography (HPLC) analysis.  
MATERIALS AND METHODS 
Collection of plant material 
Fresh root plant material of D. hatagirea was collected from 
local area of Bhopal (M.P.) in the month of August, 2019. The 
plant material were washed thoroughly with normal tap 
water followed by sterile distill water. Then plant material 
was dried under shaded condition at room temperature. 
Fresh plant materials of D. hatagirea were crushed to 
powder using grinding machine. Powder was stored at 4oC 
in tight air container bottle. 
Chemical reagents 
Alloxan (Central Drug House Pvt. Ltd., India), Glibenclamide 
tablets (Daonil; Aventis Pharma. Ltd., India) were procured 
from the authorized distributor of the company. All the 
chemicals used in this study were obtained from Hi Media 
Laboratories Pvt. Ltd. (Mumbai, India), Sigma Aldrich 
Chemical Co. (Milwaukee, WI, USA), SD Fine-Chem Chem. 
Ltd. (Mumbai, India) and SRL Pvt. Ltd. (Mumbai, India). 
Quercetin was kindly provided by Scan Research 
Laboratories, Bhopal (India). Methanol and acetonitrile were 
of HPLC grade and purchased from Merck Ltd, New Delhi, 
India. All other chemicals and solvents used were of HPLC 
and analytical grade. 
Extraction procedure 
The maceration method was followed for the extraction. 42 
gm powder of dried plant material was added into 100 ml of 
70 % methanol in an Erlenmeyer flask (250 ml capacity) and 
resulting mixture was vortexed well. The maceration 
process was carried out in shaker incubator at with 50 rpm 
for 48-72 hrs. After this process, the extracts were filtered 
dried extract was stored in refrigerator for their future use 
in phytochemical analysis. 
Qualitative phytochemical analysis of plant extract 
The D. hatagirea extracts obtained was subjected to the 
preliminary phytochemical analysis following standard 
methods by Khandelwal and Kokate18,19 . The extract was 
screened to identify the presence or absence of various 
active principles like phenolic compounds, carbohydrates, 
flavonoids, glycosides, saponins, alkaloids, fats or fixed oils, 
protein and amino acid and tannins. 
Total flavonoids determination 
The total flavonoid content was determined using the 
method of Olufunmiso et al 20.  1 ml of 2% AlCl3 methanolic 
solution was added to 3 ml of extract or standard and 
allowed to stand for 15 min at room temperature; the 
absorbance of the reaction mixture was measured at 420 nm 
using UV/visible spectrophotometer The content of 
flavonoids was calculated using standard graph of quercetin 
and the results were expressed as quercetin equivalent 
(mg/100mg). 
Quantification of flavonoid compounds by HPLC technique 
For HPLC investigation of flavonoid compounds the 
hydroalcoholic extracts of D. hatagirea root under study 
were used as a preliminary assessment of various 
compounds. The HPLC apparatus used for analysis was 
composed of a waters equipped with a UV dual detector and 
generated data were analyzed using Waters Ace software. 
For chromatographic separation Thermo C18 column (250 X 
4.6 mm, 5μm) was applied. The chromatographic analysis 
was performed at ambient temperature on a RP-C18 
analytical column with a mobile phase composed of 
Acetonitrile: Methanol (50:50 v/v) and was isocratically 
eluted at a flow rate of 1 ml/ min. A small sample volume of 
20 μl was used for each sample run, being injected into the 
HPLC system. The chromatogram was monitored with UV 
detection at a wavelength of 256 nm. Sample volume (20 µl) 
and analysis time was 10min for both, standards and 
samples used for analysis. A quercetin was used as 
standards. A thermospectronic model of Labindia 
3000+UV/VIS Spectrophotometer with 1cm. matched quartz 
cells were used for determination of λmax. The sample 
solution was chromatographed and a concentration of 
quercetin in extract sample was found out using regression 
equation.  
In vitro anti diabetic activity of extract 
Inhibition of alpha amylase enzyme 
A total of 500 µl of test samples and standard drug (10-
50µg/ml) were added to 500 µl of 0.20 mM phosphate buffer 
(pH 6.9) containing α-amylase (0.5mg/ml) solution and 
were incubated at 25°C for 10 min. After these, 500 µl of a 
1% starch solution in 0.02 M sodium phosphate buffer (pH 
6.9) was added to each tube. The reaction mixtures were 
then incubated at 25°C for 10 min. The reaction was stopped 
with 1.0 ml of 3, 5 dinitrosalicylic acid colour reagent. The 
test tubes were then incubated in a boiling water bath for 5 
min, cooled to room temperature. The reaction mixture was 
then diluted after adding 10 ml distilled water and 
absorbance was measured at 540 nm. Control represent 
100% enzyme activity and were conducted in similar way by 
replacing extract with vehicle. 
In vivo anti diabetic activity of extract 
Animals 
Wistar rats (180-230 g) were group housed (n= 6) under a 
standard 12 h light/dark cycle and controlled conditions of 
temperature and humidity (25±2°C, 55-65%). Rats received 
standard rodent chow and water ad libitum. Rats were 
acclimatized to laboratory conditions for 7 days before 
carrying out the experiments. All the experiments were 
carried in a noise-free room between 08.00 to 15.00 h. 
Separate group (n=6) of rats was used for each set of 
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experiments. The animal studies were approved by the 
Institutional Animal Ethics Committee (IAEC), constituted 
for the purpose of control and supervision of experimental 
animals by Ministry of Environment and Forests, 
Government of India, New Delhi, India. 
Acute oral toxicity 
Acute toxicity study of the prepared extracts was carried out 
according to the Organization for Economic Co-Operation 
and Development (OECD) Guidelines-42321 the animals were 
fasted for 4 h, but allowed free access to water throughout. 
As per the OECD recommendations, the starting dose level 
should be that which is most likely to produce mortality in 
some of the dosed animals; and when there is no 
information available on a substance to be tested in this 
regard; for animal welfare reasons, The dose level to be used 
as the starting dose is selected from one of three fixed levels 
50, 100,150, 300 and 2000 mg/kg body weight orally for 4 
days of six groups of rats (n=6). Acute toxicity was 
determined as per reported method22. 
Induction of experimental diabetes in rats 
After fasting, diabetes was induced by a single 
intraperitoneal injection of 120 mg/kg body weight of 
'Alloxan monohydrate' in distilled water. The animals were 
allowed to drink 5% glucose solution overnight to overcome 
the drug-induced hypoglycaemia. These animals were tested 
for diabetes after 15 days and animals with blood glucose 
(fasting) were selected for experimentation23. 
Experimental protocol 
Five groups of rats were employed in the present study and 
each group contains six animals, as follows 
Group I: Rats served as normal-control and received the 
vehicle (0.5 ml distilled water/day/rat) 
Group II: Rats served as diabetic-control and received the 
vehicle (0.5 ml distilled water/day/rat) 
Group III: Rats (diabetic) were administered Dactylorhiza 
hatagirea (100 mg/kg p.o.) for 15 days. 
Group IV: Rats (diabetic) were administered Dactylorhiza 
hatagirea (200 mg/kg p.o.) for 15 days. 
Group V: Rats (diabetic) were administered Glibenclamide 
(600µg/kg p.o.) for 15 days.  
Bioassay 
On 15th day of treatment, blood samples were collected by 
retro-orbital plexus puncture method under mild ether 
anesthesia and serum was separated by centrifugation. 
Serum glucose, total protein, cholesterol (TC) and total 
triglyceride (TG) levels were evaluated using a commercial 
kit24. Body weights of rats were taken before and after 
treatment25.  
Statistical analysis 
Results were expressed as mean ± SEM. Data were analyzed 
with one way ANOVA for the comparison between groups, 
followed by Tukey as a post hoc test. 
RESULTS AND DISCUSSIONS 
The crude extracts so obtained after maceration extraction 
process was concentrated on water bath by evaporation the 
solvents completely to obtain the actual yield of extraction. 
The yield of hydroalcoholic extracts was found to be 8.556 
%. The results of qualitative phytochemical analysis of the 
crude powder of root of D. hatagirea were shown in Table 1. 
Hydroalcoholic extracts of D. hatagirea showed the presence 
of flavonoids, carbohydrate and saponins. The content of 
total flavonoid compounds (TFC) was expressed as 
mg/100mg of quercetin equivalent of dry extract sample 
using the equation obtained from the calibration curve: Y = 
0.06X+0.019, R2= 0.999, where X is the quercetin 
equivalent (QE) and Y is the absorbance Table 2. 
 
Table 1 Results of phytochemical screening of D. hatagirea 
S. No. Phytochemicals Tests Observation Inference 
    1. Alkaloids Iodine Test No blue colour - 
Wagner’s Test No reddish brown precipitate - 
Dragendorff’s Tests No orange brown precipitate - 
2. Flavonoids NaOH Tests Colourless + 
Shinoda Tests Colourless - 
3. Glycosides Keller-Kiliani Test No Bluish green colour - 
4. Phenols Phenol Tests No Blue colour - 
5. Saponins Foam Test Layer of foam + 
6. Tannins Gelatin Test No white precipitate - 
7. Carbohydrates Molisch’s test No violet colour + 
Fehling’s test Reddish orange precipitate - 
8. Proteins Millon’s test No white precipitate - 
 
Table 2 Estimation of total flavonoid content 
S. No. Solvents→ 
Bioactive compound↓ 
Hydroalcoholic Extract  
(Dactylorhiza hatagirea) 
1. Total flavonoid (Quercetin equivalent (QE) mg/100mg) 0.866 
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Flavonoids compounds are secondary metabolites in plants 
which play an immensely important role in human health 
and nutrition. The HPLC chromatogram of standard 
quercetin and hydroalcoholic extract are shown in Fig. 1 and 
the values are expressed in ppm. The retention time for 
standard and extract was found to be 2.596 min and 2.42min 
respectively. Characteristics parameters for standard 
quercetin was given in table 3 and results of quantitative 
estimation of quercetin in hydroalcoholic seed extract were 
given in table 4. Percentage inhibition of α-amylase activity 
by D. hatagirea root extract was estimated with acarbose as 
the positive control. D. hatagirea extract show dose 
dependent activity. IC50 value of acarbose and extract was 
found to 35.33 and 224.45 µg/ml respectively Table 5.
              
Table 3 Characteristics of the analytical method derived from the standard calibration curve 
Compound Linearity range 
μg/ml 
Correlation co-
efficient 
Slope Intercept 
Quercetin 5-25 0.999 94.39 -30.43 
Table 4 Quantitative estimation of quercetin in hydroalcoholic extract 
S. No. Extract RT Area  % Assay 
1. Dactylorhiza hatagirea 2.42 546.88 0.1421 
 
 
(A) 
 
(B) 
Figure 1 Chromatogram of (A) Standard Quercetin (B) Hydroalcoholic Extract of Dactylorhiza hatagirea 
Table 5: In vitro antidiabetic activity of D. hatagirea root extract analyzed by α-amylase inhibition assay and 
comparison with standard drug acarbose 
S. No Acarbose Dactylorhiza hatagirea 
Conc. % Inhibition % Inhibition 
1. 100 51.190 39.417 
2. 200 70.105 45.502 
3. 300 74.206 57.010 
4. 400 85.185 66.137 
5. 500 88.756 84.391 
                               IC50 ( µg/ml)                 35.33                   224.45 
 
It is well known fact that alloxan monohydrate induces 
diabetes mellitus in rats by selective necrotic action on the 
beta cells of pancreas leading to insulin deficiency. Insulin 
deficiency leads to various metabolic aberrations in animals 
like increased blood glucose level, increased levels of 
cholesterol and triglyceride and decreased protein content26. 
As expected in alloxan treated rats, there was significant 
increase in blood glucose, cholesterol (TC) and triglyceride 
(TG) levels. The diabetic animals showed significant 
decrease in blood glucose level after 15 days treatment. 
Choukarya et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2019; 9(6-s):76-81 
ISSN: 2250-1177                                                                                  [80]                                                                                 CODEN (USA): JDDTAO 
Moreover it also decreased the levels of cholesterol (TC) and 
triglyceride (TG) increased by alloxan treatment. Alloxan 
treatment of the rats has showed the loss in body weight as 
compared to normal rats. However, the hydroalcoholic 
extract was more effective and results are comparable with 
that of reference drug, gliblenclamide. Hence, we can say 
that presence of flavonoid in the ethyl acetate fraction may 
be responsible for antidiabetic activity. As shown in Table 6 
Blood glucose level of animals in all groups was recorded at 
0, 8th and 15th day. Progressive decrease in blood glucose 
level was found in all treatment groups during study. At the 
end of experiment Glibenclamide 600µg/kg, D. hatagirea 
100 and 200 mg/kg/p.o. (130.50; 150.30 and 139.40) 
treated group blood glucose level was decrease significantly 
(p<0.01) at 15thdays, respectively. 
 
Table 6 Effect of hydroalcoholic extract of D. hatagirea treatment on blood glucose (mg/dl) in normal and diabetic rats 
Group Treatment         Blood glucose (mg/dl) 
Days 0                           Days 8                               Days 15 
I Normal 90.17± 5.50                  98.00 ± 5.50                     101.30 ± 5.50 
II Diabetic Control 270.00 ± 10.35            280.00± 10.11#                       284.75± 10.12# 
III Diabetic + Dactylorhiza hatagirea 
(100 mg/kg) 
250.00  ± 4.50             150.30± 4.50***                      125.20 ± 4.50*** 
IV Diabetic + Dactylorhiza hatagirea 
(200 mg/kg) 
245.00 ± 5.00             139.40 ± 5.10***              117.80 ± 5.0*** 
V Diabetic +  Glibenclamide 
 (600µg/kg) 
240.00 ± 4.55             130.50± 4.50***               112.70 ± 4.50*** 
Values are expressed as mean±S.E.M (n = 6).Values are statistically significant at # p<0.001 vs. normal group; *P < 0.001, **P < 
0.01vs diabetic control group (Two-way ANOVA test). 
 
As shown in Table 7 Glibenclamide 600µg/kg, D. hatagirea 
100 and 200 mg/kg/p.o. treated group biochemical 
parameters like TC, TG level was decrease significantly 
(p<0.01) and total protein level was increase  as compared 
to diabetic control group. As represented in Table 8 body 
weights of animals in all groups were performed at the 
initial and end of the study. Body weight of animals was 
significantly (p<0.05) maintained in all treatment groups 
(Glibenclamide 600µg/kg, D. hatagirea 100 and 200 
mg/kg/p.o. 205, 195, 200) during study as compared to 
control group (160). 
 
Table 7 Effect of hydroalcoholic extract of D. hatagirea treatment on biochemical parameters in normal and diabetic 
rats 
Group Treatment           TC 
(mg/dL) 
         TG 
(mg/dL) 
   Total 
protein(g/dl) 
I Normal 90.00 ± 5.00 80.00 ± 5.00 8.00 ± 0.45 
II Diabetic Control 180.0 ± 6.00   153.0 ± 6.00 5.00 ± 0.50 
III Diabetic + Dactylorhiza hatagirea 
(100 mg/kg) 
109.6 ± 5.55** 95.50 ± 5.50* 7.90 ± 0.30** 
IV Diabetic + Dactylorhiza hatagirea 
(200 mg/kg) 
105.1 ± 5.10** 92.50 ± 5.56* 8.35 ± 0.45** 
V Diabetic +  Glibenclamide 
 (600µg/kg) 
101.1 ± 5.10** 89.20± 5.22* 8.75 ± 0.25** 
 
Table 8 Effects of hydroalcoholic extract of D. hatagirea on body weight 
Group Treatment Initial weight 
(gm) 
Final weight 
(gm) 
I Normal 160.00 ± 9.00 180.10 ± 9.06 
II Diabetic Control 170.00 ± 8.40   160.00 ± 8.40 
III Diabetic + Dactylorhiza hatagirea 
(100 mg/kg) 
165.00 ± 10.00 195.00 ± 7.32 
IV Diabetic + Dactylorhiza hatagirea 
(200 mg/kg) 
165.00 ± 9.20 200.00 ± 8.42 
V Diabetic +  Glibenclamide 
 (600µg/kg) 
160.00 ± 7.80 205.00 ± 8.16 
 
CONCLUSION 
From the present study, it is concluded that D. hatagirea may 
be useful in treating diabetes mellitus with no visible signs 
or symptoms of toxicity in normal rats indicating a high 
margin of safety. The hydroalcoholic extracts of D. hatagirea 
have indicated high level of anti-diabetic activity. The 
extracts exhibited anti-hyperglycemic activity comparable to 
that of a standard anti-diabetic drug, glibenclamide. The 
traditional use of D. hatagirea to treat diabetes is supported 
by laboratory results from this study, suggesting a need to 
isolate and evaluate active constituents responsible for the 
exhibited biological activity. 
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